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1684-1182/Copyright ª 2014, TaiwanBackground/Purpose: Respiratory viral infections have frequently been reported to closely
correlate with asthma exacerbations. Distinctive expression of cytokine/chemokine and anom-
alous responses of innate immunity induced by respiratory viral infections were suggested to
play a key role. This study further evaluates the effects of airway sensitization on innate im-
munity in response to different viruses.
Methods: Murine sensitization was established using an ovalbumin (OVA) sensitization model.
Mice were subsequently infected with either respiratory syncytial virus (RSV) or human metap-
neumovirus (hMPV). Type I interferon (IFN), cytokines, and chemokines were measured in
bronchoalveolar lavage (BAL) fluid. Pulmonary tissue samples were collected for the analysis
of viral titers and type I IFN signal transcriptors.
Results: Distinct expressions of cytokine/chemokine responses after viral infection were also
found in mice with OVA sensitization. A significant increase of virus replication was found in
lungs of RSV-infected sensitized mice. The increment of RSV titer was associated with the
decreased levels of type I IFN. Although Toll-like receptor 3 (TLR3) expression was significantly
increased in the lungs, the key signal transcriptor, IFN regulatory factor 3, was significantly
suppressed in the RSV-infected sensitized mice.
Conclusion: A defective antiviral innate response was observed in the murine respiratory al-
lergy model. Suppressed expression of IFN signal transcriptor contributes to decreasedof Pediatrics, Chang Gung Memorial Hospital, 5, Fu-Hsing Street, Kwei-Shan, Taoyuan, Taiwan.
org.tw (T.-Y. Lin).
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Asthma is an allergic airway disease characterized by a
chronic inflammatory reaction and airway hyper-
responsiveness (AHR). During episodes of asthma exacer-
bations, respiratory viral infections can be detected in
nearly 80e85% of school-age children and 75e80% in
adults.1,2 Respiratory syncytial virus (RSV) and human
metapneumovirus (hMPV) belong to the family of Para-
myxoviridae. They share similar clinical manifestations and
seasonal epidemics in young children.3 Both are often
detected in young children with asthma exacerbation.4e8
Whether respiratory virus induces asthma exacerbation,
or if asthmatics are more prone to respiratory viral infection
still remains an enigma. A report fromWark et al9 showed an
increased viral replication after rhinovirus inoculation in
ex vivo cultured primary bronchial epithelial cells collected
from asthmatic adults. Decreased expression of type I in-
terferons (IFNs) and inhibited apoptosis of infectedbronchial
epithelial cellswere suggested to contribute to the increased
viral replication.9 Another important antiviral immune
response is the pattern-recognition receptors (PRRs)-
induced type I IFNs production. Among these PRRs, retinoic
acid-inducible gene I (RIG-I) and Toll-like receptor 3 (TLR3)
seemed to play an important role in mediating the recogni-
tion of RSVand hMPV.10,11 pattern recognition receptor (PPR)
domains transmit signals into the nucleus through several
transcription factors. The key signal transcriptors, such as
IFN regulatory factor 3 (IRF3), IRF7, and nuclear factor-kb
(NF-kb), once activated, initiate IFNs reponses.12
In this study, we examined how sensitization affects
innate immune responses. Ovalbumin (OVA)-sensitized
mice were utilized in the infection with RSV or hMPV. The
study demonstrated that after RSV infection, sensitization
status impaired type I IFN expression, and resulted in
enhanced viral replication. Gene and protein analysis
further verified that the reduced expression of IRF3
contributed to the decline of type I IFNs.Materials and methods
Mice and viral stocks
BALB/c female mice (6e8 weeks old) were purchased from
the National Laboratory Animal Center (Taipei, Taiwan). All
mice were housed in accordance with the guidelines of Na-
tional Institute of Health for animal health care. The hMPV
strain CAN97e83 and RSV A2 were obtained from the Uni-
versity of TexasMedical Branch,Galveston, TX, USAwith kind
permission from Dr. Roberto P Garofalo (Division of Clinical
and Experimental Immunology and Infectious Diseases, Uni-
versity of Texas Medical Branch). hMPV was propagated in
LLC-MK2 cells (ATCC CCL-7), and viral titer was determinedi S-H, et al., Defective innate imm
logy, Immunology and Infection (2as described previously.13 RSV A2 was grown in HEp2 cells
(ATCC CCL-23), and viral titer was determined by a methyl-
cellulose plaque assay, as previously described.14
Experimental protocol
The study protocol is outlined as in Fig. 1. The OVA sensi-
tization and viral inoculation are described below. On Day
0, mice were immunized with 50 mg OVA (Sigma-Aldrich, St.
Louis, MO, USA) and 2 mg aluminum hydroxide. Mice were
subsequently challenged with 1% OVA solution diluted with
sterilized Phosphate Buffered Saline (PBS) daily using a
small volume nebulizer on Days 14e16. On Day 16, mice
were inoculated intranasally with purified hMPV, RSV, or
PBS. A total of 1  107 plague-forming unit (pfu) hMPV or
RSV was used for infecting one mouse. Analytic procedures
were performed on Day 17. Lung virus titers were deter-
mined on Day 21 (Day 5 postinfection). Mice were divided
into Mock, OVA mock, RSV, OVA þ RSV, hMPV, and
OVA þ hMPV groups. The detailed manipulations of each
group are shown in Fig. 1.
Sample collection
On protocol Day 17, 1 day after the last OVA challenge, mice
of the different groups were sacrificed. Bronchoalveolar
lavage (BAL) was performed with 1.0 mL of ice-cold PBS. BAL
cells were counted, fixed, and stained using the Protocol
Hema3 kit (Fisher Diagnostics, Middletown, VA, USA).
Cellular differentials of BAL fluid were determined. Super-
natants of BALfluidwere collected for determining the levels
of cytokines and chemokines. After lavage, lungs were
collected for histopathological exam or stored at80C until
real-time quantitative polymerase chain reaction (RT-qPCR)
analysis. On protocol Day 21, lungswere collected and stored
at 80C until the titration of viral titer.
Viral titration of murine lungs
Harvested murine lungs for viral titration were homoge-
nized in 1 mL Dulbecco’s Modified Eagle Medium (DMEM)
and serially log10 diluted and applied onto HEp2 cells for
RSV titration or onto LLC-MK2 cells for hMPV titration as
described above.
RT-qPCR
Harvested lungs for RT-qPCR were homogenized in 1 mL
PBS. A total of 100 mL of lung homogenate was treated with
1 mL of TRIzol reagent to extract RNA. RNA was resus-
pended in 10 mL of diethyl pyrocarbonate-treated water.
cDNA synthesis was performed using 1 mL of the RNAune responses to respiratory syncytial virus infection in ovalbumin-
014), http://dx.doi.org/10.1016/j.jmii.2014.09.001
Figure 1. Time line of experimental protocol and the treatment. Day 0 is shown as the day of intraperitoneal ovalbumin (OVA)
injection. A total of 14 days later, mice were challenged for 3 consecutive days with nebulized OVA aerosols then inoculated with
virus or phosphate buffered saline (PBS) on Day 16. Lungs for histopathological exam and bronchoalveolar lavage (BAL) fluid were
collected on Day 1 postinfection. Virus titers of lung were titrated on Day 21 (5 days postinfection). The treatments in each groups
are shown in the below table. RSV Z respiratory syncytial virus; hMPV Z human metapneumovirus.
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(Applera, Norwalk, CT, USA). A total of 2/20 mL of cDNA
suspension was used for amplification in RT-qPCR. The
mRNA expression levels of IFN-a, -b, IRF3, IRF7, NF-kb p65,
RIG-I, and TLR3 were normalized for the amount of b-actin
mRNA present in each sample.
Cytokine and chemokine profile
BAL supernatants were detected for multiple cytokines and
chemokines using the Bio-Plex Mouse Cytokine 23-Plex
panel (Bio-Rad Laboratories, Hercules, CA, USA), accord-
ing to the manufacturer’s instructions. The panel included
the following: interleukin (IL)-1a, IL-1b, IL-2, IL-3, IL-4, IL-
5, IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17,
eotaxin, granulocyte-colony stimulating factor (G-CSF),
granulocyte-macrophage-CSF (GM-CSF), IFN-g, keratino-
cyte chemoattractant (KC), monocyte chemoattractant
protein-1 (MCP-1), macrophage inflammatory protein 1
(MIP-1) a, MIP-1 b, regulated in activation, normal T cell
expressed and secreted (RANTES), and tumor necrosis fac-
tor (TNF)-a. The broad assay range was from 2.0 pg/mL to
5000 pg/mL. The levels of IFN-a and IFN-b were measured
using enzyme-linked immunosorbent assay (ELISA) kits (R&D
Systems Inc., Minneapolis, MN, USA).
Nuclear protein extraction and Western blotting
Nuclear protein was extracted from lung homogenates using
the Nuclear Extraction Kit (Affymetrix, Santa Clara, CA, USA)
according to the manufacturer’s instructions. The nuclear
protein extractions were boiled in 3  Laemmli buffer for 2
minutes and resolved on sodium dodecyl sulfatePlease cite this article in press as: Lai S-H, et al., Defective innate imm
sensitized mice, Journal of Microbiology, Immunology and Infection (2polyacrylamide gel electrophoresis (SDS-PAGE). Proteins
were transferred for 24 hours onto a Hybond-ECL nitrocellu-
losemembrane and immersing themembrane in Tris Buffered
Saline with Tween (TBST) blocking solution containing 5%
skim milk powder for 60 minutes blocked nonspecific binding
sites. After a short wash in TBST, the membranes were incu-
bated with the primary antibody overnight at 4C, followed
by a peroxidase-conjugated secondary antibody diluted in
TBST for 60minutes at room temperature. After washing, the
proteins were detected using enhanced chemiluminescence
(ECL) according to the manufacturer’s protocol. The primary
antibodies used for Western blotting are antibodies against
NF-kb p65 (Millipore, Billerica, MA, USA), IRF3 (Abcam,
Cambridge,MA,USA), IRF7 (Lifespan, Seattle,WA,USA), RIG-I
(Abgent, San Diego, CA, USA), and b-actin (Millipore).
Statistical analysis
Statistical analysis was performed using InStat software
(GraphPad, San Diego, CA, USA). Data are presented as
mean  standard error of the mean values from two to
three independent experiments. When two groups are
compared, the values are analyzed using the Mann-Whitney
U test. The p value for significance was set at 0.05.
Results
Viral infection attenuates the recruitment of
airway eosinophil in OVA-sensitized mice
To determine the effect of respiratory viral infection on
OVA challenge, we analyzed the cellular spectrum of BALune responses to respiratory syncytial virus infection in ovalbumin-
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lation. Neutrophils were the predominant cells of BAL fluid
in mice after viral inoculation. Although the ratio of airway
eosinophil of OVA-sensitized mice significantly decreased
after viral inoculation, especially after RSV infection
(Fig. 2A), the absolute number did not change (Fig. 2B).
Distinct expressions of cytokines and chemokines
in OVA-sensitized mice after viral infections
The concentrations of T helper (Th)1/Th2 cytokines,
proinflammatory cytokines, and chemokines in BAL fluid
were measured on Day 1 postinfection. Increased expres-
sion of IFN-g after viral infection was seen in all groups.
However, OVA þ RSV mice expressed higher IL-4 and lower
IL-5 than OVA mock mice (p < 0.05; Fig. 3A). A similar trend
was also found in the OVA þ hMPV group. Regarding the
proinflammatory cytokine and chemokine responses, the
OVA þ RSV group induced lower IL-1a, IL-1b, and G-CSF, but
higher MCP-1 responses than the RSV group. Nevertheless,
reduced GM-CSF production in the OVA þ hMPV mice was
the only difference observed between the hMPV groupsFigure 2. Cellular differential in bronchoalveolar lavage
(BAL) fluid. Mice were immunized intraperitoneally with oval-
bumin (OVA) and challenged with OVA aerosols for 3 consecu-
tive days. The mock group was sensitized and challenged with
phosphate buffered saline (PBS) following the same protocol.
In the last day of challenge, mice were inoculated with respi-
ratory syncytial virus (RSV), human metapneumovirus (hMPV)
or PBS. On Day 1 postinfection, BAL was performed. Cellular
differential, in relative percentage (A) and absolute count (B),
were analyzed. Data presented are means of six mice/
group  standard error of the mean (SEM) and representative
of three different experiments. *p < 0.05 relative to the OVA
mock group.
Please cite this article in press as: Lai S-H, et al., Defective innate imm
sensitized mice, Journal of Microbiology, Immunology and Infection (2(Fig. 3B and C). In general, for other cytokine/chemokine
responses, such as TNF-a, RANTES, MIP-1a, and -1b, RSV
elicited stronger responses than hMPV (Fig. 3B and C).Increasing viral replication in OVA-sensitized mice
correlates with the reduction of type I IFN
production
To clarify if OVA-sensitization can change the host’s innate
immune response to viral infection, mice with OVA immu-
nization were infected with RSV or hMPV during the last day
of OVA challenge. OVA-sensitized mice had a higher peak
viral titer than nonsensitized mice after RSV infection
(36,260  4518 pfu/g lung tissue versus 21,240  1306 pfu/g
lung tissue, p < 0.05; Fig. 4A). By contrast, there was no
difference in peak hMPV viral titer between mice with and
without OVA sensitization (Fig. 4B). Due to the fact that the
production of type I IFNs peaked at around 18e24 hours
after RSV infection,11 the levels of IFN-a and -b in BAL fluid
were measured 24 hours after infection. A significant
reduction of IFN-a and -b expression was found in OVA-
sensitized mice with RSV infection (Fig. 5A) (RSV vs.
OVA þ RSA; IFN-a: 1263  194 pg/mL vs. 282  78 pg/mL,
p < 0.005; IFN-b: 1226  125 pg/mL vs. 73  43 pg/mL,
p < 0.005). Although decreased expression of IFN-b was
also found in OVA-sensitized mice with hMPV infection,
there was no significant change in IFN-a production
(Fig. 5B; hMPV vs. OVA þ hMPV; IFN-a: 2506  286 pg/mL
vs. 2255  212 pg/mL; IFN-b: 4585  428 pg/mL vs.
3181  395 pg/mL, p < 0.05).Distinct expressions of IFN signal transcriptors in
OVA-sensitized mice responding to different
respiratory viral infections
According to previous reports, the signal transcriptors of
type I IFN production began to rise at around 6 hours post
RSV and hMPV infection, and peaked after 15e24 hours.10,11
To elucidate the distinct expression of type I IFN between
OVA-sensitized mice infected with RSV and hMPV, we
extracted RNA from murine lung homogenates 24 hours
postinfection. RNA expressions were determined by using
RT-qPCR, and normalized by internal RNA expression of b-
actin. The RNA expressions of TLR3, NF-kb p65, IRF3, IRF7,
and RIG-I were similar between allergic and mock mice
after hMPV infection (Fig. 6A). However, OVA-sensitized
mice of the RSV group showed significant suppression of
IRF3 RNA expression (Fig. 6B; expression of OVA þ RSV/
expression of RSV  100% Z 17  4%, p < 0.005), and an
increased TLR3 RNA expression (Fig. 6B; expression of
OVA þ RSV/expression of RSV  100% Z 819  283%,
p < 0.05). In addition, there were no significant differences
for the expressions of NF-kb p65, IRF7, and RIG-I after RSV
infection between the OVA-sensitized and nonsensitized
mice. To further evaluate the protein expression of IFN
signal transcriptors, we extracted nuclear protein from the
murine lung homogenates. The results further proved that
after RSV infection, OVA-sensitized mice exhibited dimin-
ished levels of nuclear IRF3 protein, but not nuclear NF-kb











































































































































































































































































































































































































































































































Figure 3. Cytokine-chemokine levels. Mice were immunized, challenged then inoculated as the protocol described in Fig. 1.
Bronchoalveolar lavage (BAL) fluid was collected on Day 1 postinfection. Th1/Th2 cytokines (A), proinflammatory cytokines (B), and
chemokines were measured. Data presented are means of six mice/group  standard error of the mean and representative of three
different experiments. *p < 0.05, **p < 0.01, and ***p < 0.005 comparing between two groups.
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Figure 4. Virus titer in lungs of ovalbumin (OVA)-sensitized
and nonsensitized mice after infection. Mice were immunized,
challenged, and infected as the protocol of Fig. 1. Five days
after infection with respiratory syncytial virus (RSV) (A) and
human metapneumovirus (hMPV) (B) (1  107 pfu/mice), lungs
were collected and homogenized. Virus titers of homogenized
lungs were then determined by using the plaque assay. Data
presented are means of six mice/group  the standard error of
the mean (SEM) and representative of three different experi-
ments. *p < 0.05 relative to RSV or hMPV group.
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Asthma exacerbation is an exaggerated lower airway
response to environmental exposure, including allergen,
viral infection, pollutant, or certain medication. Airway
inflammation is the critical component of the lower airway
response in asthma exacerbation. The pattern of the cellular
profile is different depending on the trigger of asthma
exacerbation. Instead of the eosinophilic bronchitis found in
allergen-induced exacerbation, neutrophilic bronchitis is
usually found in viral related asthma exacerbation.2 In the
murine OVA sensitizationmodel applied to the asthma study,
airway inflammation characterized by eosinophil recruit-
ment and type 2 cytokine responses was suggested to be the
key component of allergen-induced airway hyper-
responsiveness.15 However, Peebles and colleagues
concluded differently; they showed that deteriorated AHRof
allergic mice during viral infection was not associated with a
type 2 cytokine response.16 Currently,most of our knowledgePlease cite this article in press as: Lai S-H, et al., Defective innate imm
sensitized mice, Journal of Microbiology, Immunology and Infection (2regarding the mechanism of viral asthma exacerbation is
derived from the study of rhinovirus infection. Reports
showed several proinflammatory mediators, including IL-1b,
IL-6, IL-8, RANTES, and eotaxin, to be related with
rhinovirus-induced asthma exacerbation.17,18 Increased viral
replication and decreased type I IFN production after
rhinovirus inoculationwere also found in bronchial epithelial
cells collected fromasthmatics.9 Thus,wehypothesized that
viral asthma exacerbation triggered by other respiratory vi-
ruses, such as RSV and hMPV, would also demonstrate a
distinctive cytokine/chemokine response and an impaired
antiviral innate immune response.
Our study showed that neutrophil is the predominant
inflammatory cell of BAL fluid in all infected mice (RSV,
hMPV, OVA þ RSV, and OVA þ hMPV groups). Although the
percentage of eosinophils decreased significantly after
infection in the OVA-sensitized groups (OVA þ RSV and
OVA þ hMPV), the absolute cellular number was compara-
ble to the OVA mock group. This finding is compatible with
several reported studies.19,20 However, in comparison with
the results of Aeffner and Davis,20 our study showed a more
profound neutrophil response. The difference might be
caused by a higher inoculum of virus used in our study.
In the OVA-sensitized mice, our result revealed con-
flicting responses in Th2 cytokines after viral infection,
displaying a decreased IL-5 but an increased IL-4 expres-
sion. Peebles et al21 described a similar finding and
concluded that the enhanced AHR of RSV-infected OVA-
sensitized mice was not related to Th2 cytokine responses.
Currently, no reports are available regarding the effects of
hMPV infection on allergic mice; our results indicated that
hMPV elicited Th1/Th2 responses similar to that of RSV
infection. However, in the aspect of chemokine expression,
RSV induced more profound responses of MIP-1a and MIP-1
than hMPV. Significant reductions of IL-1a, IL-1b, G-CSF
and RANTES were observed which might partially be
contributed to the decreased ratio of eosinophil in OVA-
sensitized mice after infection. By contrast, expression of
KC was increased in the OVA-sensitized mice after viral
infection, especially that of RSV. In the study of Aeffner and
Davis,20 the enhanced response of KC further attenuated
the response of AHR in OVA-sensitized mice.
Our study demonstrated that after RSV infection, viral
replication was significantly augmented in the OVA-
sensitized mice. Hassantoufighi et al16 had also shown pro-
longed viral clearance in Aspergillus-sensitized cotton rats
after low-dosage RSV infection (104.5 pfu/animal),16 which
was speculated to be related to inhibited IFN-g expression.
Although our study showed decreased IFN- g in both the
OVA þ RSV and OVA þ hMPV groups, no difference was
observed in the viral titer between theOVAþ hMPVand hMPV
groups. Type I IFNs, including IFN-a and -b, are the most
important antiviral proinflammatory cytokines against viral
replication. In themicemodel, hMPV is abetter IFN-a inducer
than RSV.22 Our study further showed that hMPV also elicited
a stronger IFN-b response. However, there was no difference
in the expression of type I IFNs between the hMPV and
OVA þ hMPV groups. Reduced type I IFN production was
indeed found only in the OVAþ RSV group, which resulted in
enhanced viral replication. Bronchial epithelial cells taken
from asthmatics also expressed worsened type I IFNs pro-
duction in respond to rhinovirus infection, and thusune responses to respiratory syncytial virus infection in ovalbumin-
014), http://dx.doi.org/10.1016/j.jmii.2014.09.001
Figure 5. Type I interferon (IFN) production after viral infection in ovalbumin (OVA)-sensitized and nonsensitized mice. Mice
were immunized, challenged, and infected as in the protocol of Fig. 1. Twenty-four hours after respiratory syncytial virus (RSV) (A)
or human metapneumovirus (hMPV) (B) inoculation, bronchoalveolar lavage (BAL) fluid was collected. IFN-a and -b were measured
by using the enzyme-linked immunosorbent assay assay. Data presented are means of six mice/group  the standard error of the
mean (SEM) and representative of three different experiments. *p < 0.05, ***p < 0.005 relative to RSV or hMPV group.
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suggested that different viral infections trigger variable type
I IFNs expressions among allergic hosts.
RSV infection induces type I IFNsmainly through two signal
transduction pathways. First, replication products of RSV can
be recognized by cytosolic RNA helicases, RIG-I and mela-
noma differentiation antigen 5,11 which then ubiquitylated
TNF receptor-associated factor 3 (TRAF3) and TRAF6 and
subsequently activates the NF-kb and IRF3 pathway. Alter-
natively, TLRs are also important in the recognition of the
viral nucleic acids after RSV infection. Although TLR4 and
TLR2 have been shown to be involved in the activation of
proinflammatory cytokines,23,24 TLR3 is the most important
sensoramongTLRs in the inductionof IFNsproduction.11 TLR3
pathway also converges on a common TRAF3 adaptor com-
plex.TRAF3 thenactivates IRF3kinases, including IRF3kinase
IkB kinase ε (IKKε) and TANK binding kinase-1,25,26 which
cause phosphorylation and homodimerization of IRF3. IRF3
then translocates into the nucleus, where, together with NF-
kb, it activates type I IFN production. Liao et al10 reported a
similar signaling pathway after hMPV infection for the in-
duction of IFN production, except that RIG-I seemed to play a
more important role than TLR3 in the recognition of viral
nucleic acid. Based on previous reports and our results, all
evidence points to NF-kb and IRF3 to be the key signaling
transcriptors in IFN production after RSVand hMPV infection.
The expression of upstream sensors such as NF-kb and
RIG-1 did not differ between the OVA-sensitized and non-
sensitized mice. Although RSV significantly increased TLR3
expression in OVA-sensitized mice, such a trend was not
observed in the OVA þ hMPV group. Next, the study
regarding the downstream signal transcriptors showed a
significantly reduced IRF3 expression in OVA-sensitizedPlease cite this article in press as: Lai S-H, et al., Defective innate imm
sensitized mice, Journal of Microbiology, Immunology and Infection (2mice after RSV infection (OVA þ RSV group), both in the
protein and mRNA level. However, OVA-sensitized mice did
not exhibit similar defective IRF3 expression after hMPV
infection (OVA þ hMPV group). These evidences implied
that allergic mice expressed a distinct signaling pathway of
IFN production in response to different viral infections.
IRF3 is constitutively expressed in the cytoplasm. Viral
infection triggers IRF3 phosphorylation, which allows IRF3 to
form a homo-dimer that translocates into the nucleus and
binds to DNA. IRF3 is regulated by ubiquitination and
proteasome-dependent degradation. Several viruses have
evolved a certain ability to interfere with the activation and
function of IRF3. Zheng et al27 found that the nonstructural
protein 3 of mouse hepatitis virus A59 can cause de-
ubiquitination of IRF3 and prevent its nuclear localization.
It is well known that the nonstructural protein of RSV, NS1,
and NS2, reduces the activation of IRF3 and NF-kb, which
subsequently inhibits the induction of type I IFN.28,29 Our
report also showed that RSV induces less type I IFN expression
than hMPV. However, the exact mechanism of the interfer-
ence of IFN induction by NS still remains an enigma.
Several cellular factors have been suggested to be
involved in the negative regulation of IRF3. Cytoplasmic
peptidyl prolyl isomerase (PIN1) can bind to phosphorylated
IRF3 to trigger its ubiquitination and subsequent degrada-
tion.30 However, PIN1, a cis-trans isomerase, does not have
any effect on NF-kb activation.30 PIN1 was also shown to
play a critical role in allergic pulmonary eosinophilia in
rats.31 Our data also revealed that the expression of IRF3,
but not NF-kb, was reduced after RSV infection in the
murine allergic pulmonary model. It is possible that PIN1
may play a key role in the mechanism of defective activa-
tion of type I IFN signal transduction of allergic hosts.une responses to respiratory syncytial virus infection in ovalbumin-
014), http://dx.doi.org/10.1016/j.jmii.2014.09.001
Figure 6. Expression of signal transcriptors of type I interferon after viral infection in ovalbumin (OVA)-sensitized and non-
sensitized mice. Mice were immunized, challenged, and infected as in the protocol of Fig. 1. Twenty-four hours after infection,
lungs were collected for extraction of mRNA and nuclear protein. The relative mRNA expressions of signal transcriptors after
respiratory syncytial virus (RSV) (A) or human metapneumovirus (hMPV) (B) infection were normalized for the amount of b-actin
mRNA. Signal transcriptors, which had translocated into the nucleus, were assayed using Western blotting (C). Data presented are
means of five mice/group  the standard error of the mean (SEM) and representative of three different experiments. *p < 0.05
relative to RSV or hMPV group.
Please cite this article in press as: Lai S-H, et al., Defective innate immune responses to respiratory syncytial virus infection in ovalbumin-
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cytokine-chemokine expression after viral infection.
Inhibited production of type I IFN resulted in increased viral
replication after RSV infection in the allergic mice. We
found that the reduction of type I IFN was closely related to
the decreased expression of nuclear signal transcriptor,
IRF3. These findings suggest that allergic mice exhibit
distinct signaling transcription of innate immunity after
different viral infections.
Conflicts of interest
All contributing authors declare no conflicts of interest.
Acknowledgments
This work was supported by grants from the National Sci-
ence Council (97-2314-B-182A-055) and Chang Gung Medical
Research Program (CMRPG470141 and 470142).
References
1. Grissell TV, Powell H, Shafren DR, Boyle MJ, Hensley MJ,
Jones PD, et al. Interleukin-10 gene expression in acute virus-
induced asthma. Am J Respir Crit Care Med 2005;172:433e9.
2. Wark PAB, Johnston SL, Moric I, Simpson JL, Hensley MJ,
Gibson PG. Neutrophil degranulation and cell lysis is associated
with clinical severity in virus-induced asthma. Eur Respir J
2002;19:68e75.
3. Williams J, Harris P, Tollefson S. Human metapneumovirus and
lower respiratory tract disease in otherwise healthy infants and
children. N Engl J Med 2004;350:443e50.
4. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F,
Josephs L, et al. Community study of role of viral infections in
exacerbations of asthma in 9-11 year old children. BMJ 1995;
310:1225e9.
5. Rakes GP, Arruda E, Ingram JM, Hoover GE, Zambrano JC,
Hayden FG, et al. Rhinovirus and respiratory syncytial virus in
wheezing children requiring emergency care. Am J Respir Crit
Care Med 1999;159:785e90.
6. Ong BH, Gao Q, Phoon MC, Chow VTK, Tan WC, van Bever HP.
Identification of human metapneumovirus and Chlamydophila
pneumoniae in children with asthma and wheeze in Singapore.
Singapore Med J 2007;48:291e3.
7. Heymann P, Carper H, Murphy D. Viral infections in relation to
age, atopy, and season of admission among children hospital-
ized for wheezing. J Allergy Clin Immunol 2004;114:239e47.
8. Khetsuriani N, Kazerouni N, Erdman D. Prevalence of viral
respiratory tract infections in children with asthma. J Allergy
Clin Immunol 2007;119:314e21.
9. Wark PAB, Johnston SL, Bucchieri F, Powell R, Puddicombe S,
Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have
a deficient innate immune response to infection with rhino-
virus. Eur Respir J 2002;19:68e75.
10. Liao S, Bao X, Liu T, Lai S, Li K, Garofalo RP, et al. Role of
retinoic acid inducible gene-I in human metapneumovirus-
induced cellular signalling. J Gen Virol 2008;89:1978e86.
11. Liu P, Jamaluddin M, Li K, Garofalo RP, Casola A, Brasier AR.
Retinoic acid-inducible gene I mediates early antiviral
response and Toll-like receptor 3 expression in respiratory
syncytial virus-infected airway epithelial cells. J Virol 2007;81:
1401e11.
12. Akira S, Takeda K. Toll-like receptor signalling. Nature Rev
Immunol 2004;4:499e511.Please cite this article in press as: Lai S-H, et al., Defective innate imm
sensitized mice, Journal of Microbiology, Immunology and Infection (213. Kolli D, Bataki EL, Spetch L, Guerrero-Plata A, Jewell AM,
Piedra PA, et al. T lymphocytes contribute to antiviral immu-
nity and pathogenesis in experimental human meta-
pneumovirus infection. J Virol 2008;82:8560e9.
14. Lai SH, Stein DA, Guerrero-Plata A, Liao SL, Ivanciuc T, Hong C,
et al. Inhibition of respiratory syncytial virus infections with
morpholino oligomers in cell cultures and in mice. Mol Ther
2008;16:1120e8.
15. Drazen J, Arm J. Sorting out the cytokines of asthma. J Exp
Med 1996;183:1e5.
16. Hassantoufighi A, Oglesbee M, Richter BWM, Prince GA,
Hemming V, Niewiesk S, et al. Respiratory syncytial virus
replication is prolonged by a concomitant allergic response.
Clin Exp Immunol 2007;148:218e29.
17. Dougherty RH, Fahy JV. Acute exacerbations of asthma:
epidemiology, biology and the exacerbation-prone phenotype.
Clin Exp Allergy 2009;39:193e202.
18. Chen Y, Hamati E, Lee PK, Lee WM, Wachi S, Schnurr D, et al.
Rhinovirus induces airway epithelial gene expression through
double-stranded RNA and IFN-dependent pathways. Am J
Respir Cell Mol Biol 2006;34:192e203.
19. Peebles Jr R, Sheller J. Respiratory syncytial virus infection
prolongs methacholine-induced airway hyperresponsiveness in
ovalbumin-sensitized mice. J Med Virol 1999;57:186e92.
20. Aeffner F, Davis IC. Respiratory syncytial virus reverses airway
hyperresponsiveness to methacholine in ovalbumin-sensitized
mice. PLoS ONE 2012;7:e46660.
21. Peebles Jr R, Sheller J, Collins R. Respiratory syncytial virus
infection does not increase allergen-induced type 2 cytokine
production, yet increases airway hyperresponsiveness in mice.
J Med Virol 2001;63:178e88.
22. Guerrero-Plata A, Baron S, Poast JS, Adegboyega PA, Casola A,
Garofalo RP. Activity and regulation of alpha interferon in
respiratory syncytial virus and human metapneumovirus
experimental infections. J Virol 2005;79:10190e9.
23. Murawski MR, Bowen GN, Cerny AM, Anderson LJ, Haynes LM,
Tripp RA, et al. Respiratory syncytial virus activates innate im-
munity through Toll-like receptor 2. J Virol 2009;83:1492e500.
24. Kurt-Jones E, Popova L, Kwinn L. Pattern recognition receptors
TLR4 and CD14 mediate response to respiratory syncytial virus.
Nat Immunol 2000;1:398e401.
25. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E,
Golenbock DT, et al. IKKε and TBK1 are essential components
of the IRF3 signaling pathway. Nat Immunol 2003;4:491e6.
26. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T,
Takeda K, et al. Toll/IL-1 receptor domain-containing adaptor
inducing IFN-b (TRIF) associates with TNF receptor-associated
factor 6 and TANK-binding kinase 1, and activates two distinct
transcription factors, NF-kB and IFN-regulatory factor-3, in the
toll-like receptor signaling. Immunol 2003;171:4304e10.
27. Zheng D, Chen G, Guo B, Cheng G, Tang H. PLP2, a potent deu-
biquitinase frommurine hepatitis virus, strongly inhibits cellular
type I interferon production. Cell Res 2008;18:1105e13.
28. Spann KM, Tran KC, Chi B, Rabin RL, Collins PL. Suppression of
the induction of alpha, beta, and gamma interferons by the NS1
and NS2 proteins of human respiratory syncytial virus in human
epithelial cells and macrophages. J Virol 2004;78:4363e9.
29. Spann KM, Tran K-C, Collins PL. Effects of nonstructural pro-
teins NS1 and NS2 of human respiratory syncytial virus on
interferon regulatory factor 3, NF-kB, and proinflammatory
cytokines. J Virol 2004;78:4363e9.
30. Saitoh T, Tun-Kyi A, Ryo A, Yamamoto M, Finn G, Fujita T, et al.
Negative regulation of interferon-regulatory factor 3-depen-
dent innate antiviral response by the prolyl isomerase Pin1.
Nat Immunol 2006;7:598e605.
31. Esnault S, Rosenthal L, Shen Z. A critical role for Pin1 in allergic
pulmonary eosinophilia in rats. J Allergy Clin Immunol 2007;
120:1082e8.une responses to respiratory syncytial virus infection in ovalbumin-
014), http://dx.doi.org/10.1016/j.jmii.2014.09.001
